| Nancy Harrison |
Co-chair |
Life Sciences British Columbia, Ventures West, MSI Methylation Sciences, Creative Destruction Lab, adMare BioInnovations, Digital Technology Supercluster, Genome British Columbia, Knight Therapeutics |
| Cédric Bisson |
Co-chair |
Teralys Capital, iNovia Capital, McKinsey & Company, Montreal InVivo, Grand Challenges Canada, Procure |
| Maha Katabi |
Member |
Sofinnova, Amplyx Pharmaceuticals, Northsea Therapeutics, Oxalis Capital, Sectoral Asset Management, Ventures West Management, T2C2 Capital, Exactis Innovation |
| Gordon McCauley |
Member |
adMare BioInnovations, Viable Healthworks, Allon Therapeutics, NDI Capital, BIOTECanada, CGen, Life Sciences British Columbia, Biotechnology Innovation Organization (BIO), Acetech, Toronto Rehabilitation Institute, Toronto Rehab Foundation |
| Parimal Nathwani |
Member |
Toronto Innovation Acceleration Partners (TIAP), MaRS Discovery District, UBC University Industry Liaison Office (UILO), TRIUMF Innovations, Zucara Therapeutics, Vasomune Therapeutics, Encycle Therapeutics |
| Ali Tehrani |
Member |
Zymeworks, Student Biotechnology Network (SBN), Consortium de recherche biopharmaceutique (CQDM), Life Sciences British Columbia, Mitacs, BIOTECanada, Premier's Technology Council, Creatus Biosciences |
| Youla Tsantrizos |
Member |
McGill University, Boehringer Ingelheim, Centre de recherche en biologie structurale (CRBS), Canadian Society for Chemistry, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), Ontario Institute for Cancer Research (OICR) |
| Lisa Barrett |
Advisor |
Dalhousie University, Senescence Aging Infection & Immunity Lab (SAIL), National Institute of Allergy and Infectious Diseases (NIAID) |
| Marceline Côté |
Advisor |
University of Ottawa |
| Eleanor Fish |
Advisor |
University of Toronto, University Health Network (UHN) |
| Matthias Götte |
Advisor |
Li Ka Shing Institute of Virology, McGill University |
| François Jean |
Advisor |
Facility for Infectious Disease and Epidemic Research (FINDER) |
| Samira Mubareka |
Advisor |
Sunnybrook Health Sciences Centre, University of Toronto, Centre for Research Expertise in Occupational Disease (CREOD), Canadian COVID-19 Genomics Network (CanCOGen), Genome Canada, Ontario's COVID-19 Genomics Rapid Response Coalition (ONCoV), Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network (ONS2), Sunnybrook Translational Research Group for Emerging Respiratory Viruses (SERV) |
| Pamela Ohashi |
Advisor |
Princess Margaret Cancer Centre, University of Toronto, American Association for Cancer Research (AACR), Society for Immunotherapy of Cancer (SITC), Royal Society of Canada (RSC) |
| James Russell |
Advisor |
University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Sirius Genomics, Cyon Therapeutics, St. Paul's Hospital |
| Makeda Semret |
Advisor |
McGill University Health Centre (MUHC), Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), AAU-McGill Partnership for Infectious Diseases (AMP-ID) |
| Don Sheppard |
Advisor |
McGill University Health Centre (MUHC), McGill Interdisciplinary Initiative in Infection and Immunity (MI4) |
| Don Vinh |
Advisor |
McGill University Health Centre (MUHC), Canadian Glycomics Network (GlycoNet), Association of Medical Microbiology and Infectious Disease Canada (AMMI), Clinical Immunology Society (CIS), Comité consultatif québécois pour les maladies rares, MUHC COVID-19 Biobank, COVID-19 and Cancer Consortium (CCC19), COVID Human Genetic Effort (CHGE) |